TrialJournal of gastroenterology2015
The prospective randomized study on telaprevir at 1500 or 2250 mg with pegylated interferon plus ribavirin in Japanese patients with HCV genotype 1.
Tsugiko Oze et al.PubMed ↗Publisher ↗
No numbers read from the abstract.